Leftwich Scott bought CLDI
August 21, 2025 · Form 4 insider transaction
Leftwich Scott bought 125,000 shares of Calidi Biotherapeutics, Inc. at $2.00 per share, a transaction worth $250.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$2.00
Total value
$250.0K
InsiderLeftwich Scott
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 21, 2025
Filing dateAugust 25, 2025
Shares owned after130,650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.; Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.